Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Nuvo Research, Inc. (NRI) to Present at the ROTH Capital Partners 24th Annual Conference

Nuvo Research is a specialty pharmaceutical company engaged in building a portfolio of products for the topical treatment of pain. Through its Germany-based subsidiary, Nuvo Research GmbH, the company is additionally developing the compound WF10, an immune modulating drug candidate for the treatment of immune related diseases. Nuvo Research is a publicly traded company with its headquarters in Mississauga, Ontario, Canada. For more information visit the company’s Web site at www.nuvoresearch.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *